Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Author:

D’Ambrosio Lorenzo12ORCID,Touati Nathan3,Blay Jean‐Yves4ORCID,Grignani Giovanni2ORCID,Flippot Ronan5,Czarnecka Anna M.67,Piperno‐Neumann Sophie8,Martin‐Broto Javier9,Sanfilippo Roberta10,Katz Daniela11,Duffaud Florence12,Vincenzi Bruno13,Stark Daniel P.14,Mazzeo Filomena15,Tuchscherer Armin16,Chevreau Christine17ORCID,Sherriff Jenny18,Estival Anna19,Litière Saskia3,Sents Ward3,Ray‐Coquard Isabelle4,Tolomeo Francesco2,Le Cesne Axel5,Rutkowski Piotr67,Stacchiotti Silvia10ORCID,Kasper Bernd20ORCID,Gelderblom Hans21,Gronchi Alessandro22ORCID,

Affiliation:

1. Department of Oncology University of Turin Turin Italy

2. Sarcoma Unit, Division of Medical Oncology Candiolo Cancer Institute–FPO, IRCCS Candiolo Italy

3. European Organization for Research and Treatment of Cancer Brussels Belgium

4. Leon Berard Center and Claude Bernard Lyon I University, EURACAN, LYRICAN Lyon France

5. Department of Medicine Gustave Roussy Villejuif Cedex France

6. Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Sklodowska‐Curie Institute–Oncology Center Gliwice Poland

7. Department of Experimental Pharmacology Mossakowski Medical Research Centre, Polish Academy of Sciences Warsaw Poland

8. Medical Oncology Department Curie Institute Paris France

9. Virgen del Rocio University Hospital, Institute of Biomedicine Research/CSIC/University of Seville Seville Spain

10. Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

11. Oncology Department Sharett Institute of OncologyHadassah‐Hebrew University Jerusalem Israel

12. Medical Oncology - University Hospital Timone, Aix‐Marseille University Marseille France

13. Department of Medical Oncology Campus Bio‐Medico University of Rome Rome Italy

14. St James's Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals National Health Service Trust Leeds United Kingdom

15. Medical Oncology Clinique Universitaire Saint‐Luc Woluwe‐Saint‐Lambert Belgium

16. Department of Internal Medicine I University Hospital Cologne Cologne Germany

17. Claudius Regaud Institute, University Cancer Institute of Toulouse Toulouse France

18. Cancer Centre Queen Elizabeth Hospital Birmingham United Kingdom

19. Catalan Institute of Oncology Barcelona Spain

20. Sarcoma Unit Interdisciplinary Tumor CenterMannheim University Medical CenterUniversity of Heidelberg Mannheim Germany

21. Department of Medical Oncology Leiden University Medical Center Leiden Netherlands

22. Department of Surgery Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

Funder

European Organisation for Research and Treatment of Cancer

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3